At the end of the double-blind treatment period, those who received sunobinop reported a higher rate (41% versus 9%) of marked or moderate improvement compared to placebo in their overall IC/BPS ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for a type of bladder cancer, ...

The FDA has approved Inlexzo (gemcitabine intravesical system) for the treatment of adult patients with BCG-unresponsive, non-muscle invasive bladder cancer with CIS with or without papillary tumors.

The indication for the chemotherapy-containing system stipulates use in adults with bacillus Calmette-Guerin ...

A woman who became addicted to ketamine explained what it felt like to suffer with 'ket bladder' after she started peeing ...

The FDA has approved Inlexzo (gemcitabine intravesical system) for the treatment of certain patients with NMIBC.

The FDA approves Inlexzo, a groundbreaking treatment for bladder cancer, offering hope for patients unresponsive to ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for patients with a type of ...